1. Pink Sheet

New Talent Is In At Sanofi, Biogen

 
• By Jessica Merrill

Sanofi appointed immunology expert Yong-Jun Liu as head of research, leaving a vacancy at Medimmune, while Biogen recruited its new chief commercial officer Michel Vounatsos from Merck.

Looking to reenergize early R&D, Sanofi lured immunology expert Yong-Jun Liu away from AstraZeneca PLC, where he was head of research at the UK company’s MedImmune biologics business. At Sanofi, he will work as head of research for global R&D, reporting to President-Global R&D Elias Zerhouni, effective April 1.

Liu is a leading expert in immunology, and his research has led to the development of important drug targets in...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Agency Leadership

More from Pink Sheet

‘Prices Can Remain Contaminated Indefinitely’: Advanz Brushed Aside On UK Liothyronine Appeal

 
• By Dean Rudge

England’s Court of Appeal has upheld a Competition Appeal Tribunal’s 2023 finding that Advanz and its former owner Cinven abused their dominant position in the UK market for liothyronine tablets by charging prices that were many orders of magnitude higher than the benchmark for fair pricing.

New EU Filings

 
• By Neena Brizmohun

Linerixibat, GSK's treatment for cholestatic pruritus in patients with primary biliary cholangitis, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.

Podium Policy Returns To US FDA, Or Is It Podcast Policy?

 
• By Michael McCaughan

US FDA critics have long decried the practice of using informal communications to convey regulatory expectations as podium policy. In the Makary era, the phrase may need to be updated because the agency now seems to be specializing in policy by podcast.